ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0067

Identification of Neutrophil Extracellular Traps in Explanted Human Lungs with Rheumatoid Arthritis-related Interstitial Lung Disease

Amara Seng1, Kensuke Suga2, Diana Tran3, Anvita Singaraju4, Tanyalak Parimon5, Youn Jung Choi6, Justyna Fert-Bober7, Jon Giles8, Peter Chen5 and Nunzio Bottini9, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Beverly Hills, CA, 3Cedars Sinai Medical Center, La Cañada Flintridge, CA, 4Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, 5Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 6Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 7Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 8Cedars Sinai Medical Center, Los Angeles, CA, 9Cedars Sinai Medical Center, Beverly Hills, CA

Meeting: ACR Convergence 2025

Keywords: interstitial lung disease, neutrophils, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0067–0097) Rheumatoid Arthritis – Etiology and Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Symptomatic rheumatoid arthritis-related interstitial lung disease (RA-ILD) is prevalent in about 10% of patients with RA and confers a higher mortality compared with RA patients without ILD. Anti-citrullinated protein antibodies (ACPAs) are strongly linked to RA-ILD, suggesting a pathogenic role for citrullinated proteins. Citrullinated histone H3 (Cit H3), a component of neutrophil extracellular traps (NETs), has been identified as a potential biomarker of RA-ILD. Our aim was to quantify and characterize Cit H3 expression in explanted lungs from patients undergoing lung transplant who have RA-ILD compared to patients with other connective tissue disease (CTD)-ILD or idiopathic pulmonary fibrosis (IPF).

Methods: Formalin fixed paraffin embedded explanted lung tissues were obtained from patients with RA-ILD (n=9), other CTD-ILD (n=4) or IPF (n=6). Deceased donor lungs without known pulmonary disease (HC, n=4) were used as controls. Using immunofluorescence, CD3+, CD20+, Cit H3+ and neutrophil elastase+ (NE) cells were quantified. Single cell RNA sequencing was completed on CD45+ immune cells sorted from 5 disaggregated RA-ILD lungs.

Results: Cit H3+ cells were identified in explanted lungs with RA-ILD, other CTD-ILD and IPF. A subset of patients in each group had higher Cit H3 density in lung tissue (Fig 1C). In the RA-ILD samples, a portion of the Cit H3+ cells were also NE+ indicating the presence of NETs. The average distance of Cit H3+ cells to the nearest CD3+ cells was shorter in RA-ILD (37 µm) vs HC (214 µm) (p=0.008) (Fig 2A). The closer proximity of Cit H3+ cells to CD3+ cells in RA-ILD was independent of the number of CD3+ or Cit H3+ cells present (Fig 2B-C). Single cell RNA sequencing from RA-ILD patients with Cit H3 high (n=3) vs Cit H3 low (n=2) samples revealed non-significant trends in T cell subsets (Fig 3). In the Cit H3 high vs low groups, there were higher percentages of T peripheral helper cells (median 13.2% vs 5.1%, p=0.4) and regulatory T cells (median 23.9% vs 7.3%, p=0.2) and lower percentages of helper 17 cells (median 11.8% vs 21.8%, p=0.4), T resident memory CD8+ T cells (median 7.3% vs 24.5%, p=0.2) and cytotoxic CD8+ T cells (median 4.8% vs 11.3%, p=0.4).

Conclusion: These findings suggest a role for NETs in RA-ILD, highlighting the potential interaction of T cells with NETs. Future direction includes single cell TCR sequencing and spatial transcriptomics to further explore the interplay between T cells and NETs and its impact on the pathogenesis of RA-ILD.

Supporting image 1Figure 1: Density of Cit H3+ Cells in RA-ILD, CTD-ILD and, IPF explanted lungs. A) Representative immunofluorescence image of an FFPE section from an RA-ILD explanted lungs to show Cit-H3 (yellow), CD3 (cyan) and CD20 (red). B) Representative density maps of RA-ILD and HC lungs. Maps were generated based on raw cell counts in a 300 µm radius. The blue outline is the tissue based on Hoescht thresholding. The green outline is an area of Cit H3 density with greater than 46 Cit H3+ cells/300 µm radius. C) Percentage of Cit H3 dense areas represented by the Cit H3 dense area (green outline) divided by the total area of the tissue (blue outline). Data are represented as median ±IQR. Kruskal-Wallis test, p values < 0.5 noted above columns.

Supporting image 2Figure 2: Proximity of Cit H3+ and CD3+ cells in RA-ILD, CTD-ILD and, IPF explanted lungs. A) Average distances Cit H3 cells and the nearest CD3+ cell for HC, RA-ILD, CTD-ILD and IPF lungs. Data are represented as median ±IQR. Kruskal-Wallis test, p values < 0.5 noted above columns. Correlation of (B) relative abundance of CD3+ or (C) Cit H3+ cells (plotted as percentage of total cells) with average nearest distance between Cit H3+ and CD3+ cells. Simple linear regression, R squared and p values noted in tables below.

Supporting image 3Figure 3: Frequency of T cell subsets based on single cell RNA sequencing of CD45+ immune cells from Cit H3 high and Cit H3 low RA-ILD lung explants. Percentages of T peripheral helper cells (Tph), regulatory T cells (Treg), T helper 17 (Th17) cells, T resident memory (TRM) CD8+cells and, cytotoxic CD8+ T cells in Cit H3 high (n=3) and Cit H3 low (n=2) RA-ILD lung explants. Data are represented as median ±IQR. Mann-Whitney test, p values < 0.5 noted above columns.


Disclosures: A. Seng: None; K. Suga: None; D. Tran: None; A. Singaraju: None; T. Parimon: None; Y. Choi: None; J. Fert-Bober: None; J. Giles: AbbVie/Abbott, 2, Eli Lilly, 2, Genentech, 2, Merck/MSD, 2, Novartis, 2, Pfizer, 2, Sana, 2; P. Chen: Gilead, 1; N. Bottini: Merck/MSD, 2.

To cite this abstract in AMA style:

Seng A, Suga K, Tran D, Singaraju A, Parimon T, Choi Y, Fert-Bober J, Giles J, Chen P, Bottini N. Identification of Neutrophil Extracellular Traps in Explanted Human Lungs with Rheumatoid Arthritis-related Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/identification-of-neutrophil-extracellular-traps-in-explanted-human-lungs-with-rheumatoid-arthritis-related-interstitial-lung-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-neutrophil-extracellular-traps-in-explanted-human-lungs-with-rheumatoid-arthritis-related-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology